InsidersTradesSigma
제이투케이바이오: directors' dealings · South Korea · DART (FSS)
DART:company-941d97KR·DART (FSS)Mcap 54.9Bn€Basic Materials
Explore the full management transaction log of 제이투케이바이오, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Basic Materials sector, 제이투케이바이오 has published 1 public disclosures. Market capitalisation: €54.9bn. The latest transaction was reported on 12 May 2026 (Purchase). Among the most active insiders: 김석종. Every trade is accessible without an account.
1
Insider Decl.
0
Thresholds
€21,390
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
9390.00 €
Analyst consensus
Income statement
Revenue32.97 Bn€
Gross profit12.98 Bn€39% margin
Net income2.67 Bn€8.1% margin
Valuation
Beta0.38
Balance sheet & cash
Market cap54.91 Bn€
Total debt1.13 Bn€
Free Cash Flow944.0 M€
Debt / Equity3%
Profitability & ownership
ROE8.2%
ROA4.9%
% insiders62.1%
% institutions0.0%
Last declaration on 12 May 2026